Vitamin D Levels May Predict Response to Vedolizumab

J Crohns Colitis. 2021 Dec 18;15(12):1978-1979. doi: 10.1093/ecco-jcc/jjab105.

Authors

Giorgos Bamias¹, Jesús Rivera-Nieves^{2

3}

Affiliations

¹ GI Unit, 3rd Academic Dept. of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece.
² Inflammatory Bowel Disease Center, Division of Gastroenterology, University of California San Diego [UCSD], La Jolla, CA, USA.
³ San Diego VA Medical Center [SDVAMC], San Diego, CA, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized* / therapeutic use
Gastrointestinal Agents / therapeutic use
Humans
Vitamin D*

Substances

Antibodies, Monoclonal, Humanized
Gastrointestinal Agents
Vitamin D
vedolizumab

Grants and funding